The company continues to have a strong growth outlook ahead.Hims & Hers Health (HIMS 1.16%) demonstrated once again why it's one of the most interesting growth stocks outside of the tech sector when it reported strong Q3 results. While the stock has been volatile this year, it is trading up more than 80% in 2025, as of this writing.Let's take a closer look at the most recent earnings results for this telehealth company to see if now is a good time to buy the stock.Strong revenue growth continuesHims & Hers ...